Pages that link to "Q34993352"
Jump to navigation
Jump to search
The following pages link to Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13. (Q34993352):
Displaying 10 items.
- Rats selectively bred for low levels of play-induced 50 kHz vocalizations as a model for autism spectrum disorders: a role for NMDA receptors (Q26866047) (← links)
- Thermodynamics and Mechanism of the Interaction of Willardiine Partial Agonists with a Glutamate Receptor: Implications for Drug Development (Q27683881) (← links)
- GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects (Q30440925) (← links)
- GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Attenuates Cerebral Ischemia Injury In Vivo and Vitro by Differential Modulations of NMDA Receptors Subunit Components at Different Post-Ischemia Stage in Mice (Q33780749) (← links)
- Positive emotional learning is regulated in the medial prefrontal cortex by GluN2B-containing NMDA receptors. (Q35194637) (← links)
- Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13). (Q37741989) (← links)
- A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism (Q37896243) (← links)
- Positive Emotional Learning Induces Resilience to Depression: A Role for NMDA Receptor-mediated Synaptic Plasticity (Q38814342) (← links)
- Targeting of Glycine Site on NMDA Receptor as a Possible New Strategy for Autism Treatment (Q50313366) (← links)
- Commentary: GLYX-13 Ameliorates Schizophrenia-Like Phenotype Induced by MK-801 in Mice: Role of Hippocampal NR2B and DISC1 (Q58762928) (← links)